Market
Calcium supplement tablets in Ukraine are marketed as dietary supplements (food products) and are subject to Ukraine’s food safety, consumer information, and advertising rules. A dedicated dietary-supplement regulatory update (Law No. 4122-IX) entered into effect on September 27, 2025, tightening requirements around placing products on the market and aligning controls with the competent authority framework. Retail access is strongly associated with pharmacy-chain ecosystems and online health/beauty platforms. Ongoing wartime conditions and infrastructure disruptions remain a material risk driver for import continuity and distribution reliability.
Market RoleDomestic consumer market; import-reliant for many branded supplements
Domestic RoleRetail dietary supplement category sold in measured-dose forms (tablets/pills) under food-law framework
Risks
Geopolitical HighOngoing war conditions and martial law create elevated disruption risk for imports and domestic distribution (route changes, infrastructure damage, security constraints, and intermittent service disruption), which can delay replenishment of retail channels for supplement tablets.Use dual-route logistics planning (alternative borders/ports), maintain higher safety stock at distributor level, and contractually define force-majeure and delivery windows.
Regulatory Compliance MediumDietary supplement placing-on-market requirements were tightened with Law No. 4122-IX effective September 27, 2025; non-compliance (e.g., notification pathway, composition limits, or label/claim rules) can trigger enforcement actions, delisting, or recall exposure.Run a pre-market compliance checklist against Law No. 4122-IX, food information law requirements, and advertising/claims restrictions; keep a complete technical file (composition, specs, labeling, and substantiation).
Food Safety MediumDietary supplements are vulnerable to quality variation (e.g., incorrect declared content, contamination, or poor tablet stability) and to misleading therapeutic positioning; enforcement focus is heightened by rules prohibiting therapeutic claims for supplements.Require supplier GMP/ISO22000 controls, COAs and periodic third-party testing (identity, heavy metals where relevant, content verification), and strict review of all on-pack and online claims.
Logistics MediumBorder congestion, inspection delays, and rerouting can extend lead times; for tablets this affects availability more than product integrity, but can still raise landed costs and stockout risk.Consolidate shipments, pre-book customs brokerage capacity, and use demand-based reorder points reflecting longer and more variable lead times.
Labor & Social- Consumer protection risk: misrepresentation of products and misleading health claims are explicitly targeted by Ukraine’s tightened dietary supplement regulatory framework and advertising restrictions.
Standards- ISO 22000
- HACCP-based food safety management
- GMP (dietary supplement / food-grade manufacturing controls)
FAQ
Are calcium supplement tablets treated as medicines in Ukraine?They are commonly marketed as dietary supplements (food products) in Ukraine, which places them under the food safety and consumer information framework and makes therapeutic-effect claims in advertising prohibited for supplements.
What is a key regulatory change affecting dietary supplements in Ukraine in recent years?Law No. 4122-IX introduced an updated regulatory framework for dietary supplements, with key provisions coming into effect on September 27, 2025, tightening rules for placing dietary supplements on the market and reinforcing compliance requirements.
Can advertising for dietary supplements in Ukraine claim that the product treats disease or has a therapeutic effect?No. Ukraine’s advertising law framework prohibits referring to therapeutic effects for goods that are dietary supplements (i.e., products that do not belong to medicines).